Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients

Oral Oncology

Volumn 54, Issue , 2016, Pages 7-14

  Sonis, Stephen T ^a,b   Hashemi, Sepehr ^c   Epstein, Joel B ^d,e   Nair, Raj G ^f,g   Raber Durlacher, Judith E ^h,i  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Biomodels   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f GRIFFITH UNIVERSITY   (Australia)

^g GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Head and neck cancer; Low level laser therapy; Oral mucositis; Photobiomodulation; Radioprotection; Tumor behavior

Indexed keywords

CYTOKINE; MICRORNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER PATIENT; CELL PROLIFERATION; HEAD AND NECK CANCER; HUMAN; LOW LEVEL LASER THERAPY; ORAL MUCOSITIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR INVASION; ADVERSE EFFECTS; CHEMORADIOTHERAPY; COMPLICATION; HEAD AND NECK NEOPLASMS; METABOLISM; RADIATION INJURIES; RADIATION RESPONSE; STOMATITIS; TREATMENT OUTCOME;

CHEMORADIOTHERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LOW-LEVEL LIGHT THERAPY; RADIATION INJURIES; SIGNAL TRANSDUCTION; STOMATITIS; TREATMENT OUTCOME;

EID: 84960501726     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2016.01.005     Document Type: Review

References (82)

1. R. Fekrazad, and N. Chiniforush Oral mucositis prevention and management by therapeutic laser in head and neck cancers J Lasers Med Sci 5 2014 1 7
2. R.V. Lalla, J. Bowen, A. Barasch, L. Elting, J. Epstein, D.M. Keefe, and et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy Cancer 120 2014 1453 1461
3. R.J. Lanzafeme Photomodulation and cancer and other musings Photo Laser Surg 29 2011 3 4
4. D. Hawkins, N. Houreld, and H. Abrahamse Low level laser therapy (LLLT) as an effective therapeutic modality for delayed healing Ann NY Acad Sci 1056 2005 486 493
5. C. De, J.S. Montiero, A.N. Pinheiro, S.C. de Oliveira, G.T. Aciole, J.A. Sousa, and et al. Influence of laser phototherapy (λ660 nm) on the outcome of oral carcinogenesis on the hamster cheek pouch model: histological study Photo Laser 29 2011 741 745
6. M. Myakishev-Rempel, I. Stadler, P. Brondon, D.R. Axe, M. Friedman, P.B. Nardia, and et al. A preliminary study of the safety of red light phototherapy of tissues harboring cancer Photo Laser Surg 30 2012 551 558
7. S. Farivar, T. Malekshahabi, and R. Shiari Biological effects of low level laser therapy J Lasers Med Sci 5 2014 58 62
8. K.M. AlGhamdi, A. Kumar, and N.A. Moussa Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells Lasers Med Sci 27 2012 237 249
9. T. Karu, L. Pyatibrat, and G. Kalendo Irradiation with He-Ne laser increases ATP level in cells cultivated in vitro J Photochem Photobiol B, Biol 27 1995 219 223
10. J. Zhang, D. Xing, and X. Gao Low-power laser irradiation activates Src tyrosine kinase through reactive oxygen species-mediated signaling pathway J Cell Phys 217 2008 518 528
11. A. Bellacosa, C.C. Kumar, A. Di Cristofano, and J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv Cancer Res 94 2005 29 86
12. L. Zhang, D. Xing, X. Gao, and S. Wu Low-power laser irradiation promotes cell proliferation by activating PI3K/Akt pathway J Cell Phys 219 2009 553 562
13. Y.H. Wu, J. Wang, D.X. Gong, H.Y. Gu, S.S. Hu, and H. Zhang Effects of low-level laser irradiation on mesenchymal stem cell proliferation: a microarray analysis Lasers Med Sci 27 2012 509 519
14. F. Ginani, D.M. Soares, M.P. Barreto, and C.A. Barboza Effect of low-level laser therapy on mesenchymal stem cell proliferation: a systematic review Lasers Med Sci 30 2015 2189 2194
15. H. Tuby, L. Maltz, and U. Oron Induction of autologous mesenchymal stem cells in the bone marrow by low-level laser therapy has profound beneficial effects on the infarcted rat heart Lasers Surg Med 43 2011 401 409
16. J.Y. Wu, C.H. Chen, C.Z. Wang, M.L. Ho, M.L. Yeh, and Y.H. Wang Low-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-kappaB activity PLoS ONE 8 2013 e54067
17. X. Gao, and D. Xing Molecular mechanisms of cell proliferation induced by low power laser irradiation J Biomed Sci 16 2009 4
18. Y. Fukuzaki, H. Sugawara, B. Yamanoha, and S. Kogure 532 nm low-power laser irradiation recovers gamma-secretase inhibitor-mediated cell growth suppression and promotes cell proliferation via Akt signaling PLoS ONE 8 2013 e70737
19. V.H. Schartinger, O. Galvan, H. Riechelmann, and J. Dudas Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy Supp Care Cancer 20 2012 523 529
20. F.F. Sperandio, A. Simoes, L. Correa, A.C. Aranha, F.S. Giudice, M.R. Hamblin, and et al. Low-level laser irradiation promotes the proliferation and maturation of keratinocytes during epithelial wound repair J Biophoton 2014 doi: 10.1002
21. F.F. Sperandio, F.S. Giudice, L. Correa, D.S. Pinto Jr., M.R. Hamblin, and S.C. de Sousa Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway J Biophoton 6 2013 839 847
22. A.C. Gomes Henriques, F. Ginani, R.M. Oliveira, T.S. Keesen, C.A. Galvao Barboza, H.A. Oliveira Rocha, and et al. Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells Lasers Med Sci 29 2014 1385 1395
23. F.A. Al-Watban, and B.L. Andres Laser biomodulation of normal and neoplastic cells Lasers Med Sci 27 2012 1039 1043
24. A.C. Pellicioli, M.D. Martins, C.S. Dillenburg, M.M. Marques, C.H. Squarize, and R.M. Castilho Laser phototherapy accelerates oral keratinocyte migration through the modulation of the mammalian target of rapamycin signaling pathway J Biomed Opt 19 2014 028002
25. Y. Dang, X. Ye, Y. Weng, Z. Tong, and Q. Ren Effects of the 532-nm and 1064-nm Q-switched Nd:YAG lasers on collagen turnover of cultured human skin fibroblasts: a comparative study Lasers Med Sci 25 2010 719 726
26. Y. Dang, B. Liu, L. Liu, X. Ye, X. Bi, Y. Zhang, and et al. The 800-nm diode laser irradiation induces skin collagen synthesis by stimulating TGF-beta/Smad signaling pathway Lasers Med Sci 26 2011 837 843
27. F.M. de Lima, R. Albertini, Y. Dantas, A.L. Maia-Filho, L. Santana Cde, H.C. Castro-Faria-Neto, and et al. Low-level laser therapy restores the oxidative stress balance in acute lung injury induced by gut ischemia and reperfusion Photochem Photobiol 89 2013 179 188
28. A. Gupta, G.K. Keshri, A. Yadav, S. Gola, S. Chauhan, A.K. Salhan, and et al. Superpulsed (Ga-As, 904 nm) low-level laser therapy (LLLT) attenuates inflammatory response and enhances healing of burn wounds J Biophoton 8 2015 489 501
29. J. Feng, Y. Zhang, and D. Xing Low-power laser irradiation (LPLI) promotes VEGF expression and vascular endothelial cell proliferation through the activation of ERK/Sp1 pathway Cell Signal 24 2012 1116 1125
30. Y. Kawano, Y. Utsunomiya-Kai, K. Kai, I. Miyakawa, T. Ohshiro, and H. Narahara The production of VEGF involving MAP kinase activation by low level laser therapy in human granulosa cells Laser Ther 21 2012 269 274
31. S.M. Safavi, B. Kazemi, M. Esmaeili, A. Fallah, A. Modarresi, and M. Mir Effects of low-level He-Ne laser irradiation on the gene expression of IL-1beta, TNF-alpha, IFN-gamma, TGF-beta, bFGF, and PDGF in rat's gingiva Lasers Med Sci 23 2008 331 335
32. W.S. Kim, and R.G. Calderhead Is light-emitting diode phototherapy (LED-LLLT) really effective? Laser Ther 20 2011 205 215
33. Z. Sharifian, M. Bayat, M. Alidoust, R.M. Farahani, M. Bayat, F. Rezaie, and et al. Histological and gene expression analysis of the effects of pulsed low-level laser therapy on wound healing of streptozotocin-induced diabetic rats Lasers Med Sci 29 2014 1227 1235
34. M. Esmaeelinejad, and M. Bayat Effect of low-level laser therapy on the release of interleukin-6 and basic fibroblast growth factor from cultured human skin fibroblasts in normal and high glucose mediums J Cosmet Laser Ther 15 2013 310 317
35. A. Usumez, B. Cengiz, S. Oztuzcu, T. Demir, M.H. Aras, and N. Gutknecht Effects of laser irradiation at different wavelengths (660, 810, 980, and 1064 nm) on mucositis in an animal model of wound healing Lasers Med Sci 29 2014 1807 1813
36. J. Szymanska, K. Goralczyk, J.J. Klawe, M. Lukowicz, M. Michalska, B. Goralczyk, and et al. Phototherapy with low-level laser influences the proliferation of endothelial cells and vascular endothelial growth factor and transforming growth factor-beta secretion J Physiol Pharm 64 2013 387 391
37. S. Song, F. Zhou, and W.R. Chen Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases J Neuroinflam 9 2012 219
38. L. Zhang, Y. Zhang, and D. Xing LPLI inhibits apoptosis upstream of Bax translocation via a GSK-3beta-inactivation mechanism J Cell Physiol 224 2010 218 228
39. G. Shefer, T.A. Partridge, L. Heslop, J.G. Gross, U. Oron, and O. Halevy Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells J Cell Sci 115 2002 1461 1469
40. H. Zhang, S. Wu, and D. Xing Inhibition of Abeta (25-35)-induced cell apoptosis by low-power-laser-irradiation (LPLI) through promoting Akt-dependent YAP cytoplasmic translocation Cell Signal 24 2012 224 232
41. J. Chu, S. Wu, and D. Xing Survivin mediates self-protection through ROS/cdc25c/CDK1 signaling pathway during tumor cell apoptosis induced by high fluence low-power laser irradiation Cancer Lett 297 2010 207 219
42. T. Kushibiki, T. Hirasawa, S. Okawa, and M. Ishihara Regulation of miRNA expression by low-level laser therapy (LLLT) and photodynamic therapy (PDT) Int J Mol Sci 14 2013 13542 13558
43. J. Wang, W. Huang, Y. Wu, J. Hou, Y. Nie, H. Gu, and et al. MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation through inhibitor of growth family, member 5 Stem Cells Dev 21 2012 2508 2519
44. B. Fronza, T. Somacal, L. Mayer, J.F. de Moraes, M.G. de Oliveira, and J.B. Weber Assessment of the systemic effects of low-level laser therapy (LLLT) on thyroid hormone function in a rabbit model Int J Oral Maxillo Surg 42 2013 26 30
45. J.B. Weber, L. Mayer, R.A. Cenci, C.E. Baraldi, D. Ponzoni, and M. Gerhardt de Oliveira Effect of three different protocols of low-level laser therapy on thyroid hormone production after dental implant placement in an experimental rabbit model Photo Laser Surg 32 2014 612 617
46. V.S. Hentschke, R.B. Jaenisch, L.A. Schmeing, P.R. Cavinato, L.L. Xavier, and P. Dal Lago Low-level laser therapy improves the inflammatory profile of rats with heart failure Lasers Med Sci 28 2013 1007 1016
47. N. Chalhoub, and S.J. Baker PTEN and the PI3-kinase pathway in cancer Ann Rev Pathol 4 2009 127 150
48. D.R. Simpson, L.K. Mell, and E.E. Cohen Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck Oral Oncol 51 2015 291 298
49. Y.H. Chen, M.F. Wei, C.W. Wang, H.W. Lee, S.L. Pan, M. Gao, and et al. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer Cancer Lett 357 2015 582 590
50. A.J. Leiker, W. DeGraff, R. Choudhuri, A.L. Sowers, A. Thetford, J.A. Cook, and et al. Radiation enhancement of head and neck squamous cell carcinoma by the dual PI3K/mTOR inhibitor PF-05212384 Clin Cancer Res 21 2015 2792 2801
51. L. Chang, P.H. Graham, J. Hao, J. Ni, J. Bucci, P.J. Cozzi, and et al. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance Cell Death DIs 4 2013 e875
52. X. Cui, S. Li, T. Li, X. Pang, S. Zhang, J. Jin, and et al. Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma Int J Clin Exp Pathol 7 2014 2382 2391
53. J. Ni, P. Cozzi, J. Hao, J. Beretov, L. Chang, W. Duan, and et al. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway Int J Biochem Cell Biol 45 2013 2736 2748
54. S. Yanamoto, G. Kawasaki, I. Yoshitomi, T. Iwamoto, K. Hirata, and A. Mizuno Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy Oral Oncol 43 2007 869 877
55. K. Pardali, and A. Moustakas Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer Biochim Biophys Acta 1775 2007 21 62
56. Y.S. Hwang, K.K. Park, and W.Y. Chung Stromal transforming growth factor-beta 1 is crucial for reinforcing the invasive potential of low invasive cancer Arch Oral Biol 59 2014 687 694
57. S.S. Prime, M. Davies, M. Pring, and I.C. Paterson The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II) Crit Rev Oral Biol Med 15 2004 337 347
58. F.R. Mangone, F. Walder, S. Maistro, F.S. Pasini, C.N. Lehn, M.B. Carvalho, and et al. Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients Mol Cancer 9 2010 106
59. M. Vassilakopoulou, A. Psyrri, and A. Argiris Targeting angiogenesis in head and neck cancer Oral Oncol 51 2015 409 415
60. J.D. Schultz, K. Muhlheim, P. Erben, R.D. Hofheinz, A. Faber, C. Thorn, and et al. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Ralpha/beta expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro Oncol Rep 26 2011 1099 1109
61. S. Ninck, C. Reisser, G. Dyckhoff, B. Helmke, H. Bauer, and C. Herold-Mende Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck Int J Cancer 106 2003 34 44
62. B. Han, J. Liu, M.J. Ma, and L. Zhao Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer World J Gastroen: WJG 11 2005 2188 2192
63. Q. Gu, D. Wang, X. Wang, R. Peng, J. Liu, H. Deng, and et al. Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. II. The RAS/MAPK pathway and phosphorylation of BAD at serine 112 Radiat Res 161 2004 703 711
64. X. Yin, H. Zhang, K. Lundgren, L. Wilson, F. Burrows, and C.G. Shores BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy Int J Cancer 126 2010 1216 1225
65. K. Patel, J. Wen, K. Magliocca, S. Muller, Y. Liu, Z.G. Chen, and et al. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation Cancer Chemot Pharmacol 74 2014 1015 1022
66. G. Lorenzo, L. Vintro, and C.P. deMadrid HSP-90 expression as a predictor of response in radiotherapy in head and neck cancer patients Acto Otorrhinolaryngol ESP 2015 S0001-6519
67. E.L. Rosenthal, and L.M. Matrisian Matrix metalloproteases in head and neck cancer Head Neck 28 2006 639 648
68. L.F. Jia, S.B. Wei, K. Mitchelson, Y. Gao, Y.F. Zheng, Z. Meng, and et al. MiR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14 PLoS ONE 9 2014 e108435
69. J. Bu, X. Bu, B. Liu, F. Chen, and P. Chen Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment Tumour Biol 36 2015 2695 2701
70. I. Gunawardena, M. Arendse, M.B. Jameson, L.D. Plank, and R.T. Gregor Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis × antigen ANZ J Surg 2013 doi: 10.1111
71. D. Liu, H. Guo, Y. Li, X. Xu, K. Yang, and Y. Bai Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis PLoS ONE 7 2012 e31251
72. T. Ettl, S. Viale-Bouroncle, M.G. Hautmann, M. Gosau, O. Kolbl, T.E. Reichert, and et al. AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines Oral Oncol 51 2015 158 163
73. E.M. Peek, W. Song, H. Zhang, J. Huang, and A.I. Chin Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes Prostate 75 2015 463 473
74. A.T. Koch, L. Love-Homan, M. Espinosa-Cotton, A. Stanam, and A.L. Simons MyD88-dependent signaling decreases the antitumor efficacy of epidermal growth factor receptor inhibition in head and neck cancer cells Cancer Res 75 2015 1657 1667
75. M.J. Szczepanski, M. Czystowska, M. Szajnik, M. Harasymczuk, M. Boyiadzis, A. Kruk-Zagajewska, and et al. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack Cancer Res 69 2009 3105 3113
76. D.B. Hofling, M.C. Chavantes, M.M. Acencio, G.G. Cerri, S. Marui, E.M. Yoshimura, and et al. Effects of low-level laser therapy on the serum TGF-beta1 concentrations in individuals with autoimmune thyroiditis Photo Laser Surg 32 2014 444 449
77. M. Perera, C.S. Tsang, R.J. Distel, J.N. Lacy, L. Ohno-Machado, V. Ricchiuti, and et al. TGF-beta1 interactome: metastasis and beyond Cancer Genom Proteomics 7 2010 217 229
78. C. Migliorati, I. Hewson, R. Lalla, H.S. Antunes, C. Estilo, B. Hodgson, and et al. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients Support Care Cancer 21 2013 2508 2519
79. G. Ciais, M. Namer, M. Schneider, F. Demard, N. Pourreau-Schneider, P.M. Martin, and et al. Laser therapy in the prevention and treatment of mucositis by anticancer chemotherapy Bull Cancer 79 1992 183 191
80. A. Barascj, D.E. Peterson, J.M. Tanzer, J.A. D'Ambrosio, K. Nuki, M.M. Schubert, and et al. Helium-neon laser effects on conditioning-induced mucositis in bone marrow transplantation patients Cancer 76 1995 2550 2556
81. E.A. Eisenhauer, P. Therrasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, and et al. New response evaluation criteria in solid tumors: revised RECIST guidelines Eur J Cancer 45 2009 228 247
82. NAALT standards, Toronto, Canada; 2006.